bioRxivMicrobiologyPreprint
Cultivation of host-adapted Cryptosporidium parvum and Cryptosporidium hominis using enteroids for cryopreservation of isolates and transcriptomic studies of infection
M. Deng, T. Hou, X. Mao, J. Zhang, F. Yang, Y. Wei, Y. Tang, W. Zeng, W. Huang, N. Li, Y. Feng, L. Xiao, Y. Guo
Abstract
Cryptosporidium hominis and Cryptosporidium parvum are major causes of severe diarrhea in humans. Comparative studies of them are hampered by the lack of effective cultivation and cryopreservation methods, especially for C. hominis. Here, we described adapted murine enteroids for the cultivation of one C. parvum IId subtype and nonhuman primate-adapted C. hominis Ib, Im, and In subtypes, which allowed the complete development of the pathogens, producing oocysts infectious to mice. Using the system, we developed a novel cryopreservation method for Cryptosporidium isolates. In comparative RNA-seq analyses of C. hominis cultures, the enteroid system generated significantly more transcriptomic responses of both pathogen and host genes than the conventional HCT-8 cell system. In particular, the infection was shown to upregulate PI3K-Akt, Wnt, Ras,TNF, NF-{kappa}B, IL-17, MAPK, and innate immunity signaling pathways and downregulate Wnt and Hippo signaling pathways, host cell metabolism, and parasites in enteroid cultures had significantly higher expression of genes involved in oocyst formation. Therefore, the new culture model provides a valuable tool for comparative studies of the biology of divergent Cryptosporidium species. IMPORTANCE The two dominant species for human cryptosporidiosis, Cryptosporidium hominis and Cryptosporidium parvum, differ significantly in host range and virulence. Up to date, biological studies of Cryptosporidium spp. are almost exclusively done with bovine-adapted IIa subtypes of C. parvum, which is the species with effective laboratory animal models and in vitro cultivation methods. Here, we describe modified procedures for the generation of murine enteroids for successful cultivation of both nonhuman primate-adapted C. hominis subtypes and a C. parvum IId subtype, producing oocysts infective to mice. In addition, we have developed a novel cryopreservation method using the system for long-term storage of Cryptosporidium isolates. RNA-seq analyses of C. hominis cultures indicate that the enteroid culture system generates host and pathogen transcriptomic responses similar to those in natural infection. This new development alleviates a technical bottleneck in cryptosporidiosis research, and provides an example for other difficult-to-culture pathogens of major public health importance.
- organism: mouse
- organism: non-human primate
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cryopreservation of Infectious Cryptosporidium parvum Oocysts
J. Jaskiewicz, R. Sandlin, … T. Saul·bioRxiv·May 31, 2018
- A Cell Culture Platform For Cryptosporidium That Enables Long-Term Cultivation And New Tools For The Systematic Investigation Of Its Biology
C. N. Miller, L. Josse, … A. Tsaousis·bioRxiv·May 4, 2017
- Cryptosporidium infection of human small intestinal epithelial cells induces type III interferon and impairs infectivity of Rotavirus.
V. Greigert, I. Saraav, … L. D. Sibley·bioRxiv·Aug 30, 2023
- Organoid-based in vitro system and reporter for the study of Cryptosporidium parvum sexual reproduction
B. R. Korwin-Mihavics, E. A. Dews, … C. D. Huston·bioRxiv·Sep 29, 2023
- A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognition
A. R. Gibson, A. Sateriale, … B. Striepen·bioRxiv·Oct 6, 2021
- A multiplex PCR assay for the detection of Cryptosporidium species and simultaneous differentiation of Cryptosporidium hominis, Cryptosporidium parvum in clinical stool samples
M. Katiyar, S. Padukone, … R. Singh·bioRxiv·Mar 22, 2023